Psychiatry and Neurology, Neurology · Du Bois, PA
NPI
1942320122
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
145 Hospital Ave, Suite 211
Du Bois, PA, 15801
Phone (814) 375-2070
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
818 services
Medicare patients, 2024
489
Average age 70
Drug cost, 2024
$1.8M
8,729 prescriptions
Company payments, 2025
$3,944
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oksana N Palatna was code 99214 (office e&m - established), 563 times for 376 patients. In total Oksana N Palatna billed 818 services in 20 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 563 | 376 | $65.12 | $37K |
| 99205 Office E&M - New | Facility | 52 | 52 | $120.68 | $6,276 |
| 95819 Neurologic | Facility | 43 | 43 | $42.16 | $1,813 |
| 99214 Office E&M - Established | Office | 18 | 14 | $56.51 | $1,017 |
| 95816 Neurologic | Facility | 16 | 16 | $42.32 | $677 |
| 99215 Office E&M - Established | Facility | 14 | 14 | $101.06 | $1,415 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $26.99 | $297 |
By year: 2022 $59K for 997 services; 2023 $54K for 773 services; 2024 $56K for 818 services.
Medicare prescription drug claims, 2024
In 2024, the drug Oksana N Palatna prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 532 prescriptions and refills. In total Oksana N Palatna wrote 8,729 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 532 | 867 | 117 | $16K |
| Levetiracetam Generic | 523 | 867 | 94 | $14K |
| Topiramate Generic | 421 | 604 | 68 | $5,399 |
| Lamotrigine Generic | 420 | 719 | 77 | $6,175 |
| Donepezil Hcl Generic | 410 | 691 | 85 | $7,333 |
| Gabapentin Generic | 385 | 615 | 93 | $5,020 |
| Lacosamide Generic | 276 | 335 | 34 | $35K |
| Clonazepam Generic | 252 | 267 | 45 | $1,751 |
| Baclofen Generic | 224 | 340 | 50 | $3,778 |
| Buspirone Hcl Generic | 217 | 317 | 53 | $1,859 |
| Cyclobenzaprine Hcl Generic | 204 | 236 | 44 | $986 |
| Duloxetine Hcl Generic | 199 | 305 | 41 | $5,478 |
| Pregabalin Generic | 182 | 236 | 28 | $3,301 |
| Memantine Hcl Generic | 164 | 237 | 30 | $2,221 |
| Propranolol Hcl Generic | 164 | 235 | 29 | $2,194 |
Brand drugs: 729 claims; generic drugs: 8,000 claims; opioid claims: 139.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oksana N Palatna $3,944 ($3,944 in general payments such as food, travel and fees) from 22 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $831.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 73 | $831 |
| Biogen, Inc. BIIB | 15 | $459 |
| Abbvie Inc. ABBV | 22 | $457 |
| MDD US Operations, LLC | 9 | $312 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $252 |
| Lundbeck LLC | 22 | $245 |
| Genentech USA, Inc. ROG.SW | 10 | $202 |
| UCB, Inc. UCB.BR | 11 | $188 |
| ACADIA Pharmaceuticals Inc ACAD | 8 | $185 |
| Celgene Corporation BMY | 17 | $175 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.